Drug Profile
Research programme: biotherapeutic proteins - Promosome
Latest Information Update: 28 Feb 2020
Price :
$50
*
At a glance
- Originator Promosome
- Class Anticoagulants; Biological proteins; Proteins
- Mechanism of Action Enzyme replacements; RNA modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alpha 1-antitrypsin deficiency; Haemophilia; Lysosomal storage diseases; Metabolic disorders
Most Recent Events
- 28 Feb 2020 No recent reports of development identified for research development in Alpha-1-antitrypsin-deficiency in USA (Parenteral)
- 28 Feb 2020 No recent reports of development identified for research development in Haemophilia in USA (Parenteral)
- 28 Feb 2020 No recent reports of development identified for research development in Lysosomal storage diseases in USA (Parenteral)